Last updated: 4 February 2020 at 11:02am EST

Amy Vanden Berg Net Worth




The estimated Net Worth of Amy Vanden Berg is at least $32.6 Tysiąc dollars as of 6 August 2019. Amy Berg owns over 2,500 units of Obalon Therapeutics Inc stock worth over $32,586 and over the last 8 years Amy sold OBLN stock worth over $0.

Amy Berg OBLN stock SEC Form 4 insiders trading

Amy has made over 2 trades of the Obalon Therapeutics Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Amy bought 2,500 units of OBLN stock worth $10,000 on 6 August 2019.

The largest trade Amy's ever made was exercising 6,650 units of Obalon Therapeutics Inc stock on 29 January 2018 worth over $6,451. On average, Amy trades about 832 units every 50 days since 2016. As of 6 August 2019 Amy still owns at least 11,764 units of Obalon Therapeutics Inc stock.

You can see the complete history of Amy Berg stock trades at the bottom of the page.



What's Amy Berg's mailing address?

Amy's mailing address filed with the SEC is 5421 Avenida Encinas f, Carlsbad, CA 92008, USA.

Insiders trading at Obalon Therapeutics Inc

Over the last 8 years, insiders at Obalon Therapeutics Inc have traded over $0 worth of Obalon Therapeutics Inc stock and bought 3,260,355 units worth $6,939,913 . The most active insiders traders include Parters Vii L Pblair James ..., Partners X Lp Inter West Ma... oraz David Moatazedi. On average, Obalon Therapeutics Inc executives and independent directors trade stock every 54 days with the average trade being worth of $432,771. The most recent stock trade was executed by William J. Plovanic on 12 November 2019, trading 65,000 units of OBLN stock currently worth $107,900.



What does Obalon Therapeutics Inc do?

Obalon Therapeutics, Inc. is a San Diego-based company focused on developing and commercializing novel technologies for weight loss.



Complete history of Amy Berg stock trades at Obalon Therapeutics Inc

Osoba
Trans.
Transakcja
Łączna cena
Amy Vanden Berg
Chief Clinical i Reg Officer
Kupować $10,000
6 Aug 2019
Amy Vanden Berg
Chief Clinical i Reg Officer
Opcja Ćwiczenie $6,451
29 Jan 2018


Obalon Therapeutics Inc executives and stock owners

Obalon Therapeutics Inc executives and other stock owners filed with the SEC include: